MORPH CLINICAL SERVICES LIMITEDActive

Company number 12947349Private limited companyIncorporated 2020
⚠ Confirmation statement overdue. It was due on 24 Oct 2026.

Key figures

£200,113+85.9%
Net assets 2025
+98.0%
Average annual growth 2020/21–2025
0100 k200 k300 k2020/212021/222022/232023/242025

Like most small UK companies, MORPH CLINICAL SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2020/212021/222022/232023/242025
Filed accounts2020/21–2025
2020/212021/222022/232023/242025
Cash at bank and in hand————29,168
Total assets19,369150,062242,888155,074219,749
Total liabilities6,36087,405122,267162,96819,636
Net assets / total equity13,00962,657120,621107,667200,113
Average number of employees023912

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MORPH CLINICAL SERVICES LIMITED

Company

MORPH CLINICAL SERVICES LIMITED is a private limited company registered with Companies House under company number 12947349. It was incorporated on 13 Oct 2020. Its status is active. The registered office is in Newcastle upon tyne (NE4). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files abridged accounts (unaudited). Net assets were £200,113, up 85.9% on the previous year. Cash at bank and in hand was £29,168. Total assets were £219,749 and total liabilities £19,636. The company had an average of 12 employees. Figures are available for 5 financial years (2020/21–2025).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 24 Oct 2026.